FDA puts Wayne biopharm firm's lead new drug candidate on the fast track

FDA fast track designation was awarded to Palvella Therapeutics' experimental treatment for a rare, inherited and debilitating condition called Pachyonychia congenita.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news